Simcor and Reclast drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Simcor (niacin; simvastatin) and Reclast (zoledronic acid). Common drug interactions include flushing among females and activities of daily living impaired among males.
The phase IV clinical study analyzes what interactions people have when they take Simcor and Reclast. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.
What is Simcor?
Simcor has active ingredients of niacin; simvastatin. It is often used in high blood cholesterol. eHealthMe is studying from 11,604 Simcor users. Check the latest studies of Simcor.
What is Reclast?
Reclast has active ingredients of zoledronic acid. It is often used in osteoporosis. eHealthMe is studying from 15,774 Reclast users. Check the latest studies of Reclast.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
12 people who take Simcor and Reclast together, and have interactions are studied.

What are the common drug interactions of Simcor and Reclast, by gender? *:
female:
- Flushing (the warm, red condition of human skin)
- Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
- Impaired healing
- Abdominal discomfort
- Foot fracture
- Injection site haemorrhage (bleeding from injection site)
- Injection site pain
- Seasonal allergy (allergic condition due to certain season)
- Feeling hot
- Pruritus (severe itching of the skin)
male:
- Activities of daily living impaired
- Anaemia postoperative
- Fracture nonunion (permanent failure of healing following a broken bone)
- Gait disturbance
- Groin pain
- Hypoaesthesia (reduced sense of touch or sensation)
- Impaired healing
- Joint range of motion decreased (disease of joint movement)
- Limb asymmetry (consistent task discrepancy between the two lower limbs)
- Muscular weakness (muscle weakness)
What are the common drug interactions of Simcor and Reclast, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
- Activities of daily living impaired
- Anaemia postoperative
- Arthralgia (joint pain)
- Bone pain
- Carpal tunnel syndrome (nerve compression at wrist results numbness weakness, pain , swelling)
- Comminuted fracture (bone has broken into several pieces)
- Fall
- Femur fracture
- Fracture delayed union (delayed cure of broken bone)
- Fracture displacement
40-49:
n/a
50-59:
- Abdominal discomfort
- Foot fracture
- Impaired healing
- Injection site haemorrhage (bleeding from injection site)
- Injection site pain
- Seasonal allergy (allergic condition due to certain season)
- Erythema (redness of the skin)
- Feeling hot
- Flushing (the warm, red condition of human skin)
- Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
60+:
- Flushing (the warm, red condition of human skin)
- Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
- Anaemia postoperative
- Arthralgia (joint pain)
- Blood glucose decreased
- Bone pain
- Cardiac disorder
- Cardiac failure congestive
- Carpal tunnel syndrome (nerve compression at wrist results numbness weakness, pain , swelling)
- Dizziness
What are the existing conditions these people have? *
- Depression: 3 people, 25.00%
- Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 3 people, 25.00%
- Urinary Tract Infection: 2 people, 16.67%
- Hyperlipidaemia (presence of excess lipids in the blood): 2 people, 16.67%
- Diabetes: 2 people, 16.67%
- Stress And Anxiety: 2 people, 16.67%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 16.67%
- Arthropathy: 2 people, 16.67%
- Migraine (headache): 2 people, 16.67%
- High Blood Pressure: 1 person, 8.33%
* Approximation only. Some reports may have incomplete information.
Do you take Simcor and Reclast?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Simcor and Reclast:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Simcor:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Reclast:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Simcor and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Reclast and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on niacin; simvastatin and zoledronic acid (the active ingredients of Simcor and Reclast, respectively), and Simcor and Reclast (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Buspirone Hcl cause Back Pain? - 16 seconds ago
- Could Hydramine cause Rash Maculo-Papular? - 20 seconds ago
- Could Hydrea cause Glaucoma Aggravated? - 20 seconds ago
- Could Buspar cause Acute Severe Asthma? - 22 seconds ago
- Could Simvastatin cause Normochromic Normocytic Anaemia? - 26 seconds ago
- Could Bupropion Hydrochloride cause Postmenopausal Haemorrhage? - 27 seconds ago
- Could Xyrem cause Face Oedema? - 35 seconds ago
- Could Phenergan cause Dyspnea Paroxysmal Nocturnal? - 51 seconds ago
- Adrenal Disorder and Back Pain - 51 seconds ago
- Could Bupivacaine cause Joint Swelling? - 59 seconds ago